The recent Wei Zexi incident exposed the unreliable information of biological immunotherapy. As a result, ineffective medical treatment delayed the opportunity of treatment and became one of the factors leading to Wei Zexi's death. What about dccik biological immunotherapy? Is dccik biological immunotherapy true?

How about dccik biological immunotherapy?

A DC-CIK biological immunotherapy claimed by many hospitals to treat cancer has recently attracted social attention. The reporter learned from the Second Hospital of Shanxi Medical University on the 5th that the Department of Biological Oncology in the hospital has suspended the application of DC-CIK technology in clinical treatment.

The relevant person in charge of the hospital said that the hospital is conducting self-examination on the efficacy of DC-CIK technology according to the requirements of the health department; In addition, the contract with the company providing DC-CIK technology has expired. In view of the above situation, the department of biological oncology in our hospital suspended the application of this technology in clinical treatment.

The reporter noted that since the 4th, the website of the Department of Tumor Biotherapy of the Second Hospital of Shanxi Medical University has been unable to log in, and it still shows "under maintenance". Previously, the website said that the hospital was a "large public third-class hospital" ... The oncology department adopted the latest tumor treatment technologies such as biological cell immunotherapy and DC-CIK autologous cell immunotherapy ... "

At present, cellular immunotherapy is regarded as a lifesaver by many cancer patients. At present, cellular immunotherapy widely used in China includes DC, CIK and CIK Special Zone. Some media reported that on May 4th, the National Health and Family Planning Commission held a video conference to make it clear that cellular immunotherapy is still in the clinical research stage. Participants revealed that the official request to stop its application in clinical treatment is limited to clinical research.

Is dccik biological immunotherapy true?

1. They said it was imported from the United States, but they searched the English page of DC-CIK from Google, but there was little content.

2. There is no paper about this technology at home and abroad.

3. I read the biography of Jobs, in which he talked about his treatment method, saying that he started to use a new treatment method at 1 1, which was carried out by a group of top scientists. He is either the first person to go ashore or the last person to drown. The description of this method is that cancer cells can be identified and eliminated. It is similar to the description of DC-CIK therapy, but it was used in China three years ago.

4. I found that this company operates this therapy in China: /Shengwuzhiliao.php The introduction of this page shows that this technology was made by him, and it was not imported from the United States at all, but all his big hospital customers claimed to have imported it from the United States. Last year, this website had an English page that introduced foreign customers to see a doctor in China, indicating that there was no such technology abroad. This page has been lost this year.

Last year, I saw a news on the Internet that scientists had discovered a new protective enzyme that could break through the surface of cancer cells. This enzyme is equivalent to the camouflage of cancer cells and can prevent him from being attacked by drugs. This is also contrary to what he said, "CIK cells have a mechanism to recognize tumors." I didn't search this news this year. If you need help, I can look for it patiently.

6. Is there any way to test the therapeutic effect? Can you test how much the number of cancer cells in the body has decreased? I don't know about that. The hospital told me that you can take a film one month after treatment to check whether the lump is small, because my mother didn't have a big lump under her armpit at that time, so she went back to her hometown after treatment and didn't go to check it. But my mom said she didn't feel anything. My mother has a lymph node mass under her arm after breast cancer surgery. And our neighboring village has been treated and died within a few months. Moreover, the hospital guarantees to extend the life 1-2 years or even longer.

What is autologous cell immunotherapy?

Autologous cell immunotherapy, also known as cell therapy in biological immunotherapy, mainly includes three kinds of immune cell therapy-DC cell therapy, CIK cell therapy and DCCIK cell therapy. The specific method is to extract immature immune cells (blood collection) from patients, activate them in the laboratory to make them have the ability to identify and kill liver disease cells efficiently, and then transfuse them to patients. Patients only need to cooperate with blood collection and blood transfusion without hospitalization.

The advantages of treatment are: by collecting human autoimmune cells and culturing them in vitro, the number is multiplied by thousands, and then the targeted killing function of immune cells is enhanced, and then reinjected into the human body, killing pathogens, cancer cells and mutant cells in blood and tissues, breaking the immune tolerance of the body, activating and enhancing the immunity of the body, and playing a dual role in treatment and prevention.

The Hepatology Cell Therapy Center of Harbin Infectious Disease Hospital keeps pace with the times, and has established long-distance consultation and scientific research cooperation with many authoritative medical institutions at home and abroad, forming three characteristic technologies with "autologous cell immunotherapy for hepatitis B, SCT cell transplantation for liver cirrhosis and multicellular biotherapy for liver cancer" as the core, which are in line with international standards and leading in China.

Autoimmune therapy is a new remarkable treatment mode for hepatitis B, hepatitis C, liver cirrhosis and liver cancer, and it is also a new autoimmune anti-hepatitis virus treatment method. It uses a variety of cells to fight the liver virus. The principle of use is: the immune cells collected from patients are cultured in vitro by biotechnology and amplified and then returned to patients, so as to attack virus cells in patients accurately, directionally and actively and destroy the survival of viruses.

DC-CIK cell therapy technology is an immune cell therapy technology, which combines DC and CIK cells to treat hepatitis B. These two kinds of cells were cultured separately and reinfused in a reasonable way. Cultured mature DC is presented to CD8+T cells and CD4+T cells through abundant antigen peptide-MHC class I molecular complexes and antigen peptide-MHC class II molecular complexes on its membrane surface, which directly stimulates T cells to produce specific anti-HBV immune effects. CIK cells kill hepatocytes infected by hepatitis B virus by exerting their cytotoxicity and secreting cytokines. The combination of the two can ensure the effective treatment of hepatitis B virus.

It is found that the number of DC in patients with hepatitis B is obviously less than that in healthy people, and their morphological development is immature, and the expression of costimulatory molecules CD80 and CD86 is also obviously reduced, indicating that there are abnormalities and defects in the number of DC and antigen presentation function in patients with hepatitis B, which may be one of the important reasons for HBV infection. Therefore, if we can increase the number and/or improve the function of DC in patients with HBV infection, it will help to eliminate HBV.